Short answer
SOLENO THERAPEUTICS INC (SLNO) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2025 earnings results disclosed via press release attached as exhibit: full financials in accompanying exhibit.
SOLENO THERAPEUTICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2025 earnings results disclosed via press release attached as exhibit: full financials in accompanying exhibit
- Filing structured as Reg FD-style disclosure; not "filed" under Exchange Act Section 18, limiting shareholder litigation exposure
- Investors should reference the exhibit directly for revenue, earnings, and operational metrics
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SOLENO THERAPEUTICS INC 8-K filings
Get the next SLNO 8-K as it lands
Follow SLNO for push alerts, or ask the research agent what this filing means.